| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/16/2007 | US20070191347 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 08/16/2007 | US20070191346 3-Cyano-quinoline derivatives |
| 08/16/2007 | US20070191338 Combinations comprising staurosporines |
| 08/16/2007 | US20070191337 Annellated carbamyl-aza-heterocyclic compounds, a focused library, pharmaceutical compositions, and methods of preparing the same |
| 08/16/2007 | US20070191330 Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases |
| 08/16/2007 | US20070191328 Isoquinoline compounds |
| 08/16/2007 | US20070191311 P2x receptor inhibitor |
| 08/16/2007 | US20070191294 Short interfering rna (sirna) analogues |
| 08/16/2007 | US20070191288 Treatments for Benign Tumors, Cancers, Neoplasias, and/or Other Inflammatory Disorders or Diseases |
| 08/16/2007 | US20070191260 Novel indole derivative for alkylating specific base sequence of dna and alkylating agent and drug containing the derivative |
| 08/16/2007 | US20070190647 Isolation and use of solid tumor stem cells |
| 08/16/2007 | US20070190634 Compositions useful as inhibitors of protein kinases |
| 08/16/2007 | US20070190612 31 Human Secreted Proteins |
| 08/16/2007 | US20070190577 Biologically active synthetic thyrotropin and cloned gene for producing same |
| 08/16/2007 | US20070190576 Mitogenic oxygenase regulators |
| 08/16/2007 | US20070190561 Nucleotide sequences coding polymerase for use in identifying modulators to treat cell proliferative disorders; enzyme inhibitors; antitumor agents |
| 08/16/2007 | US20070190191 Use of geraniol in antitumoral therapy |
| 08/16/2007 | US20070190132 Pharmaceutical compositions for oral and topical administration |
| 08/16/2007 | US20070190128 Suitable for favoring the intracellular delivery of pharmacologically active compounds, facilitating their transmembrane transport, or for promoting their interaction with specific cell membrane sites (receptors) |
| 08/16/2007 | US20070190106 Phosphorus-containing compounds & uses thereof |
| 08/16/2007 | US20070190076 A bacterial preparation consisting of freeze dried, non-denatured Mycobacterium bovis and water, in an amount effective to stimulate leukocytic regulatory cells, used for the prevention and/or the treatment of cancer, autoimmune diseases, allergies and tuberculosis; vaccines |
| 08/16/2007 | US20070190074 Modified hpv e6 and e7 genes and proteins useful for vaccination |
| 08/16/2007 | US20070190073 Bioconjugation; stimulates production of Th1-associated cytokines, lymphocytes, suppresses production of allergen-specific antibodies, reduces allergen-stimulated IgE production |
| 08/16/2007 | US20070190071 9-Substituted 8-oxoadenine compound |
| 08/16/2007 | US20070190054 Prevention and treatment of complement-associated disorders |
| 08/16/2007 | US20070190051 Administering monoclonal antibody or an antigen-binding portion thereof that specifically binds to and activates human CD40; Gene therapy; nucleic acid coding immunoglobulins; anticancer agents |
| 08/16/2007 | US20070190040 Recombinant p53 adenovirus methods and compositions |
| 08/16/2007 | US20070189963 Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
| 08/16/2007 | DE102006017600A1 Nucleosidanaloga als Genexpressionsregulatoren bei Viren Nucleoside analogs as regulators of gene expression in viruses |
| 08/16/2007 | DE102006005937A1 New fredericamycin derivatives are topoisomerase I inhibitors useful to treat tumor, parasite, immunosupression and neurodermititis |
| 08/16/2007 | DE102006005936A1 New fredericamycin derivatives are topoisomerase I inhibitors useful to treat tumor, parasite, immunosupression and neurodermititis |
| 08/16/2007 | CA2642665A1 Anti-cancer pharmaceutical composition |
| 08/16/2007 | CA2641579A1 N-hydroxyacrylamide compounds |
| 08/16/2007 | CA2641350A1 Aminoindazole derivatives |
| 08/16/2007 | CA2641347A1 Indazole-heteroaryl derivatives |
| 08/16/2007 | CA2641310A1 Igf-ir antagonists as adjuvants for treatment of prostate cancer |
| 08/16/2007 | CA2641169A1 Antigenic gm-csf peptides and antibodies to gm-csf |
| 08/16/2007 | CA2640652A1 Novel coumarin derivative having antitumor activity |
| 08/16/2007 | CA2639924A1 Inhibitors of e1 activating enzymes |
| 08/16/2007 | CA2638889A1 Anti-met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products |
| 08/16/2007 | CA2638040A1 Treatment of metastatic breast cancer |
| 08/16/2007 | CA2637817A1 Vitamin d analog - nel, methods and uses thereof |
| 08/16/2007 | CA2637302A1 Vitamin d analog-rak, methods and uses thereof |
| 08/16/2007 | CA2623729A1 Combinations comprising a cdk inhibitor and a growth factor antibody or anti-mitotic |
| 08/15/2007 | EP1818328A1 Chromatographic method for the isolation and purification of taxane derivatives |
| 08/15/2007 | EP1818325A2 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 08/15/2007 | EP1818052A1 Use of formoterol in the prophylactic and/or therapeutic treatment of muscle wasting and/or cachectic syndrome which are associated with catabolic conditions of certain diseases, such as cancer, aids, infections, diabetes and others |
| 08/15/2007 | EP1818008A1 Noninvasive measurements of chemical substances |
| 08/15/2007 | EP1817336A2 Auristatins having an aminobenzoic acid unit at the n terminus |
| 08/15/2007 | EP1817295A1 Triazole compounds that modulate hsp90 activity |
| 08/15/2007 | EP1817279A2 17,20(z)-dehydro vitamin d analogs and their uses |
| 08/15/2007 | EP1817278A2 2-methylene-18,19-dinor-1alfa-hydroxy-homopregnacalciferol and its uses |
| 08/15/2007 | EP1817059A2 Conjugates of 1,8-bis-naphthalimides with an antibody |
| 08/15/2007 | EP1817057A1 Ptpase inhibitors and t-cell activators for treating cancer |
| 08/15/2007 | EP1817055A2 Ovr110 antibody compositions and methods of use |
| 08/15/2007 | EP1817054A1 Naturally occuring igm antibodies that bind lymphocytes |
| 08/15/2007 | EP1817038A2 Combination comprising zd6474 and an antiandrogen |
| 08/15/2007 | EP1817020A2 Histone deacetylase inhibitors |
| 08/15/2007 | EP1816996A1 Methods and therapeutic compositions comprising plant extracts for the treatment of cancer |
| 08/15/2007 | EP1673092B1 Heterocycle-substituted pteridine derivatives and their use in therapy |
| 08/15/2007 | EP1663244B1 Pteridine derivatives for the treatment of tnf-alpha-related diseases. |
| 08/15/2007 | EP1543001B1 Pyrazolopyridine derivatives as tgf beta signal transduction inhibitors for the treatment of cancer |
| 08/15/2007 | EP1534715B1 Furopyridine and furopyrimidine derivatives for the treatment of hyper-proliferative disorders |
| 08/15/2007 | EP1467974B1 Benzimidazole derivatives and their use as gnrh antagonists |
| 08/15/2007 | EP1448531B1 3-cyanoquinolines as inhibitors of egf-r and her2 kinases |
| 08/15/2007 | EP1437349B1 Substituted isoxazoles and the use thereof as antibiotics |
| 08/15/2007 | EP1435947B1 2-phenyl benzimidazoles and imidazo-¬4,5|-pyridines as cds1/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer |
| 08/15/2007 | EP1368028B1 Benzimidazole compounds for modulating ige and inhibiting cellular proliferation |
| 08/15/2007 | EP1355588B1 Device for delivery of therepeutic agents |
| 08/15/2007 | EP1343488B1 Treatment of statin side effects |
| 08/15/2007 | EP1339458B1 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity |
| 08/15/2007 | EP1292568B1 Benzamide ligands for the thyroid receptor |
| 08/15/2007 | EP1280552B1 Methods of treating skin cancer using compositions comprising an inhibitor of endothelin receptor b |
| 08/15/2007 | EP1272614B1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 08/15/2007 | EP1254251B1 Neurosteroids as markers for alzheimer's disease |
| 08/15/2007 | EP1250137B1 Jak/stat pathway inhibitors and the use thereof for the treatment of primary generalized osteoarthritis |
| 08/15/2007 | EP1238070B1 Therapeutically useful synthetic oligonucleotides |
| 08/15/2007 | EP1198254B1 Carrier-drug conjugate |
| 08/15/2007 | EP1108023B1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor |
| 08/15/2007 | EP1067933B1 Semi-synthetic ecteinascidins |
| 08/15/2007 | EP0981618B1 Anti-apo-2 antibody |
| 08/15/2007 | EP0869975B1 Assay for and uses of peptide hormone receptor ligands |
| 08/15/2007 | EP0752874B1 Enhanced virus-mediated dna transfer |
| 08/15/2007 | CN1332030C Polypeptide, its coding sequence and preparation method and application of fungus galactose agglutinin protein activity |
| 08/15/2007 | CN1332018C Freezing dried mycobatctericsis preparation and its preparing method and use |
| 08/15/2007 | CN1331887C Lymphoma specific chimeric monoclonal antibody against HLA-DR10 |
| 08/15/2007 | CN1331885C Tumor antigen protein and peptide antigen in a tumor - testis antigens, the application to medication of hepatocellular cancer / lung cancer |
| 08/15/2007 | CN1331848C Tricyclic steroid hormone nuclear receptor modulators |
| 08/15/2007 | CN1331841C Resveratrol derivative and its production method and uses |
| 08/15/2007 | CN1331836C C60 trans-succinate with biologic activity and its synthesis |
| 08/15/2007 | CN1331526C Method for producing turmeric stable prepn. |
| 08/15/2007 | CN1331502C Chinese medicine composition |
| 08/15/2007 | CN1331490C Chinese medicine for treating tumour |
| 08/15/2007 | CN1331481C Method for extracting medicinal and edible substance from dictyoptera |
| 08/15/2007 | CN1331469C Use of dipolymer of phthalide |
| 08/15/2007 | CN1331468C Plant extractive for treating cancer |
| 08/15/2007 | CN1331463C Method for chemo-prevention of prostate cancer |
| 08/15/2007 | CN101018810A Anti-synoviolin antibody |
| 08/15/2007 | CN101018785A Thiazolinone 2-substituted quinolines |
| 08/15/2007 | CN101018780A Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors |